Login / Signup
Anti-VEGF-A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study.
Anne Wolf
Thomas Langmann
Published in:
EMBO molecular medicine (2020)
Keyphrases
</>
vascular endothelial growth factor
endothelial cells
angiotensin ii
wound healing